1. patient with known hypersensitivity or intolerance to comirnaty® or polyethylene glycol (peg). 2. patient with previous receiveing mrna vaccine ( pfizer, moderna or other). 3. pregnancy with gestational age less than 12 weeks. 4. patient with history of immunosuppessive drug ( oral , iv, im ) of which discontinue less than 6 month or any immunological abnormality which impact to antibody production and t cell function ( eg hypergammaglobulinemia, active immne deficiency). 5. patient with previous used of intravenous immunoglobulin in previous 6 month 6. patient with history of abnormal coagulation or contraindication for intramuscular injection or intradermal injection. 7. patient with end stage disease or disease with life expectancy less than 2 years 8. patient with previous use of medication interfere with serum interferon other cytokine system or disease with cytokine abnormalities. 9. patient with history of abnormal platelet or platelet dysfunction, blood coagulopathy abnormality. 10. patient with active pulmonary tuberculosis or systemic tuberculosis, atypical non mycobacterium tuberculosis.

1. patient with known hypersensitivity or intolerance to comirnaty® or polyethylene glycol (peg). 2. patient with previous receiveing mrna vaccine ( pfizer, moderna or other). 3. pregnancy with gestational age less than 12 weeks. 4. patient with history of immunosuppessive drug ( oral , iv, im ) of which discontinue less than 6 month or any immunological abnormality which impact to antibody production and t cell function ( eg hypergammaglobulinemia, active immne deficiency). 5. patient with previous used of intravenous immunoglobulin in previous 6 month 6. patient with history of abnormal coagulation or contraindication for intramuscular injection or intradermal injection. 7. patient with end stage disease or disease with life expectancy less than 2 years 8. patient with previous use of medication interfere with serum interferon other cytokine system or disease with cytokine abnormalities. 9. patient with history of abnormal platelet or platelet dysfunction, blood coagulopathy abnormality. 10. patient with active pulmonary tuberculosis or systemic tuberculosis, atypical non mycobacterium tuberculosis.

patient with known hypersensitivity or intolerance to comirnaty® or polyethylene glycol (peg). patient with previous receiveing mrna vaccine ( pfizer, moderna or other). pregnancy with gestational age less than 12 weeks. patient with history of immunosuppessive drug ( oral , iv, im ) of which discontinue less than 6 month or any immunological abnormality which impact to antibody production and t cell function ( eg hypergammaglobulinemia, active immne deficiency). patient with previous used of intravenous immunoglobulin in previous 6 month patient with history of abnormal coagulation or contraindication for intramuscular injection or intradermal injection. patient with end stage disease or disease with life expectancy less than 2 years patient with previous use of medication interfere with serum interferon other cytokine system or disease with cytokine abnormalities. patient with history of abnormal platelet or platelet dysfunction, blood coagulopathy abnormality. patient with active pulmonary tuberculosis or systemic tuberculosis, atypical non mycobacterium tuberculosis.

patient with known hypersensitivity or intolerance to comirnaty® or polyethylene glycol (peg). patient with previous receiveing mrna vaccine ( pfizer, moderna or other). pregnancy with gestational age less than 12 weeks. patient with history of immunosuppessive drug ( oral , iv, im ) of which discontinue less than 6 month or any immunological abnormality which impact to antibody production and t cell function ( eg hypergammaglobulinemia, active immne deficiency). patient with previous used of intravenous immunoglobulin in previous 6 month patient with history of abnormal coagulation or contraindication for intramuscular injection or intradermal injection. patient with end stage disease or disease with life expectancy less than 2 years patient with previous use of medication interfere with serum interferon other cytokine system or disease with cytokine abnormalities. patient with history of abnormal platelet or platelet dysfunction, blood coagulopathy abnormality. patient with active pulmonary tuberculosis or systemic tuberculosis, atypical non mycobacterium tuberculosis.

1. patient with known hypersensitivity or intolerance to comirnaty® or polyethylene glycol (peg). 2. patient with previous receiveing mrna vaccine ( pfizer, moderna or other). 3. pregnancy with gestational age less than 12 weeks. 4. patient with history of immunosuppessive drug ( oral , iv, im ) of which discontinue less than 6 month or any immunological abnormality which impact to antibody production and t cell function ( eg hypergammaglobulinemia, active immne deficiency). 5. patient with previous used of intravenous immunoglobulin in previous 6 month 6. patient with history of abnormal coagulation or contraindication for intramuscular injection or intradermal injection. 7. patient with end stage disease or disease with life expectancy less than 2 years 8. patient with previous use of medication interfere with serum interferon other cytokine system or disease with cytokine abnormalities. 9. patient with history of abnormal platelet or platelet dysfunction, blood coagulopathy abnormality. 10. patient with active pulmonary tuberculosis or systemic tuberculosis, atypical non mycobacterium tuberculosis.

1. patient with known hypersensitivity or intolerance to comirnaty® or polyethylene glycol (peg). 2. patient with previous receiveing mrna vaccine ( pfizer, moderna or other). 3. pregnancy with gestational age less than 12 weeks. 4. patient with history of immunosuppessive drug ( oral , iv, im ) of which discontinue less than 6 month or any immunological abnormality which impact to antibody production and t cell function ( eg hypergammaglobulinemia, active immne deficiency). 5. patient with previous used of intravenous immunoglobulin in previous 6 month 6. patient with history of abnormal coagulation or contraindication for intramuscular injection or intradermal injection. 7. patient with end stage disease or disease with life expectancy less than 2 years 8. patient with previous use of medication interfere with serum interferon other cytokine system or disease with cytokine abnormalities. 9. patient with history of abnormal platelet or platelet dysfunction, blood coagulopathy abnormality. 10. patient with active pulmonary tuberculosis or systemic tuberculosis, atypical non mycobacterium tuberculosis.